ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 083

Running out of Rheum: Where Are the Pediatric Rheumatology Faculty?

McKenzie Vater1, Miriah Gillispie-Taylor2, Emma Austenfeld3 and Julia Shalen4, 1Vanderbilt University Medical Center, Nashville, TN, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3MCWAH, Wauwatosa, WI, 4Johns Hopkins University, Baltimore, MD

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Education, Pediatric rheumatology, Workforce

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Quality, Health Services, and Education I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: The pediatric rheumatology workforce shortage has significant downstream effects on pediatric trainees and patients. Currently, 9 out of 50 states do not have a board-certified pediatric rheumatologist. Earlier identification and treatment of rheumatic disease leads to improved outcomes. Without recognition of these signs by general providers, patients are not referred in a timely manner, but without proper education, we cannot expect them to understand the protean presentation of rheumatic disease. A 2004 study showed that 40% of US pediatric residency programs lacked on-site pediatric rheumatologist, while one-third of medical schools had the same deficiency. The purpose of this project was to identify whether increased attention to workforce shortage issues impacted the number of US and Puerto Rico pediatric residency training programs with associated pediatric rheumatology faculty from 2004 to present.

Methods: One research team member (MV) identified all pediatric residency programs accredited for the 2022-2023 academic year through the Accreditation Council for Graduate Medical Education (ACGME) website. MV then reviewed all websites to identify those that had affiliated pediatric rheumatology faculty. In cases that were unclear, MV emailed programs with the address provided on the ACGME report. Another team member (JS) discussed programs that were unable to be categorized based on their website or via email at a meeting of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Medical Education Workgroup. Members of the working group, all practicing pediatric rheumatologists or rheumatology fellows, were queried and able to categorize most remaining programs.

Results: 212 pediatric residency programs are accredited for the 2022-2023 academic year by the ACGME in the US and Puerto Rico. 181 programs indicated presence/absence of pediatric rheumatology faculty on their website. Of the remaining 31 programs, 18 did not respond to email inquiries. Of the 212 total accredited pediatric residency programs, 132 (62.3%) have pediatric rheumatology faculty, 77 (36.3%) do not have pediatric rheumatology faculty and 1.4% remain unknown.

Conclusion: Over one-third of all pediatric residency programs do not have a pediatric rheumatologist on faculty, unchanged since 2004. This creates a significant barrier to providing appropriate education in rheumatology for trainees and limits exposure to patients with rheumatologic conditions. Lack of robust rheumatology knowledge impacts patient care and limited exposure to the field likely contributes to declining fellow match rates—most recently 62.8% positions filled for 2022, down from 69.2% in 2021. Next steps include establishing areas of essential knowledge in pediatric rheumatology for pediatric residents with the goal of creating precise learning objectives so programs can focus their educational efforts and better prepare pediatric residents for identifying and managing pediatric rheumatologic issues after graduation. Additionally, efforts should continue to understand resident motivation to pursue fellowship in pediatric rheumatology with the goal of improving recruitment given the known workforce shortage.


Disclosures: M. Vater: None; M. Gillispie-Taylor: Pfizer, 5; E. Austenfeld: None; J. Shalen: None.

To cite this abstract in AMA style:

Vater M, Gillispie-Taylor M, Austenfeld E, Shalen J. Running out of Rheum: Where Are the Pediatric Rheumatology Faculty? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/running-out-of-rheum-where-are-the-pediatric-rheumatology-faculty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/running-out-of-rheum-where-are-the-pediatric-rheumatology-faculty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology